Doptelet Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

doptelet

swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombocytopeni - antihemorrhagics - doptelet er indiceret til behandling af svær trombocytopeni hos voksne patienter med kronisk leversygdom, der er planlagt til at blive en invasiv procedure. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. kortikosteroider, immunglobuliner).

Lamictal 100 mg tyggetabletter/dispergible tabletter Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

lamictal 100 mg tyggetabletter/dispergible tabletter

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 100 mg

Lamictal 200 mg tyggetabletter/dispergible tabletter Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

lamictal 200 mg tyggetabletter/dispergible tabletter

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 200 mg

Lamictal 25 mg tyggetabletter/dispergible tabletter Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

lamictal 25 mg tyggetabletter/dispergible tabletter

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 25 mg

Lamictal 50 mg tyggetabletter/dispergible tabletter Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

lamictal 50 mg tyggetabletter/dispergible tabletter

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 50 mg